Goodman Noah
SEC insider (Form 3/4/5 filer). CIK 0002060075. Chief Business Officer at Kymera Therapeutics, Inc. (KYMR). 14 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in WATERTOWN, MA.
Companies Goodman Noah has filed insider reports for
- Kymera Therapeutics, Inc. (KYMR): Officer, Chief Business Officer
Goodman Noah
CIK: 0002060075
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kymera Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jul 1, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect3.4K shares at avg. $114.29$387K - Jun 25, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect5K shares at avg. $21.05$105K - Jun 25, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect2.5K shares at avg. $119.00$298K - Jun 25, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect2.5K shares at avg. $109.00$273K - Jun 22, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $21.05$53K - Jun 22, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect2.5K shares at avg. $99.00$248K - Apr 14, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.3K shares at avg. $90.00$121K - Apr 10, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect2K shares at avg. $87.35$175K - Apr 9, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $21.05$53K - Apr 9, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect2.5K shares at avg. $89.00$223K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 3,389 | $114.29 | $387,329 | Direct |
| Jun 25, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 5,000 | $21.05 | $105,250 | Direct |
| Jun 25, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,500 | $119.00 | $297,500 | Direct |
| Jun 25, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,500 | $109.00 | $272,500 | Direct |
| Jun 22, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 2,500 | $21.05 | $52,625 | Direct |
| Jun 22, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,500 | $99.00 | $247,500 | Direct |
| Apr 14, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,347 | $90.00 | $121,230 | Direct |
| Apr 10, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,000 | $87.35 | $174,700 | Direct |
| Apr 9, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 2,500 | $21.05 | $52,625 | Direct |
| Apr 9, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,500 | $89.00 | $222,500 | Direct |
1-10 of 14 transactions